-+ 0.00%
-+ 0.00%
-+ 0.00%

The Bull Case For Curtiss-Wright (CW) Could Change Following Cheswick Expansion And Earnings Upgrades - Learn Why

Simply Wall St·08/03/2026 05:21:39
Listen to the news
  • Curtiss-Wright recently benefited from higher analyst earnings estimates ahead of the June 2026 reporting season and announced an US$80,000,000 expansion of its Cheswick, Pennsylvania facility to support naval and nuclear programs.
  • This combination of rising expectations and capacity investment highlights how investors are focusing on Curtiss-Wright’s earnings consistency and long-cycle defense and nuclear exposure.
  • Next, we’ll examine how the upgraded earnings expectations and Cheswick expansion reshape Curtiss-Wright’s broader investment narrative for investors.

Find 55 companies with promising cash flow potential yet trading below their fair value.

Curtiss-Wright Investment Narrative Recap

To own Curtiss-Wright today, you need to believe in its ability to turn long-cycle defense and nuclear programs into dependable earnings, even as the stock already screens as expensive on most traditional metrics. The key near term catalyst is whether upcoming earnings justify those higher analyst estimates, while the biggest risk is that any slowdown or timing hiccups in large defense or nuclear contracts could expose investors to more volatility. The Cheswick expansion supports the long-cycle story but does not remove that contract timing risk.

The Cheswick, Pennsylvania expansion stands out as the clearest link between current expectations and Curtiss-Wright’s long-term thesis, because it directly increases capacity for naval and nuclear work that underpins much of the company’s backlog. For investors watching short term catalysts, this project ties recent estimate upgrades to tangible bricks-and-mortar investment in programs that can influence both revenue visibility and execution risk over the next few years.

Yet despite the optimism, the concentration in a few large naval and nuclear programs is a risk investors should be aware of if those projects ever face...

Read the full narrative on Curtiss-Wright (it's free!)

Curtiss-Wright's narrative projects $4.5 billion revenue and $735.8 million earnings by 2029. This requires 7.7% yearly revenue growth and about a $224.7 million earnings increase from $511.1 million today.

Uncover how Curtiss-Wright's forecasts yield a $814.83 fair value, a 13% upside to its current price.

Exploring Other Perspectives

CW 1-Year Stock Price Chart
CW 1-Year Stock Price Chart

While consensus expects steady progress, the most cautious analysts saw revenue only reaching about US$4.6 billion and earnings about US$775 million by 2029, reminding you that views on contract timing and margin pressure can differ sharply and that both the Cheswick expansion and naval program risks may reshuffle those expectations.

Explore 4 other fair value estimates on Curtiss-Wright - why the stock might be worth as much as 20% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Curtiss-Wright research is our analysis highlighting 2 key rewards that could impact your investment decision.
  • Our free Curtiss-Wright research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Curtiss-Wright's overall financial health at a glance.

Ready For A Different Approach?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.